Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 4 1

Status

Completed 4Recruiting 3

Sponsor Class

OTHER 4

Study Type

Interventional 3Observational 1

Sponsor

Cancer Type

Plasma cell 4Lymphoid 2Other hematologic neoplasm 1

Conditions

Neoplasms 24Breast Neoplasms 11Prostatic Neoplasms 10Colorectal Neoplasms 10Hematologic Neoplasms 7Ovarian Neoplasms 6Lung Neoplasms 5Precursor Cell Lymphoblastic Leukemia-Lymphoma 4Multiple Myeloma 4Advanced Cancer 4Uterine Cervical Neoplasms 3Rectal Neoplasms 3Lymphoma 3Head and Neck Neoplasms 3Gastrointestinal Neoplasms 3Sarcoma 2Peritoneal Neoplasms 2Pain 2Neoplasm Metastasis 2Mouth Neoplasms 2Melanoma 2Low Anterior Resection Syndrome 2Hematopoietic and Lymphoid System Neoplasm 2Fatigue 2Endometrial Neoplasms 2Depression 2Colorectal Neoplasms, Hereditary Nonpolyposis 2Colonic Neoplasms 2Brain Neoplasms 2Bone Neoplasms 2

Interventions

Dexamethasone 362Bortezomib 231Lenalidomide 200Cyclophosphamide 174Melphalan 154Calcium Dobesilate 107Peripheral Blood Stem Cell Transplantation 92fludarabine phosphate 84Thalidomide 81Filgrastim 71carfilzomib 68pomalidomide 66Granulocyte Colony-Stimulating Factor 60Mycophenolic Acid 59Busulfan 57daratumumab 54Whole-Body Irradiation 54Tacrolimus 51ixazomib 50Prednisone 50Cyclosporine 49fludarabine 46Antilymphocyte Serum 35Etoposide 30dexamethasone acetate 29Methotrexate 29plerixafor 27Radiotherapy 26Doxorubicin 26dexamethasone 21-phosphate 25

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Completed × Multiple Myeloma × Interviews as Topic × Clear all
NCT05511428 2025-11-21

Home Based Daratumumab Administration for Patients With Multiple Myeloma

Thomas Jefferson University

Phase 4 Completed
20 enrolled 38 charts
Plasma cell

Multiple Myeloma

NCT06063603 2025-09-18

ASCENT

Mayo Clinic

Phase NA Completed
51 enrolled 8 charts
LymphoidPlasma cell

Lymphoma, Multiple Myeloma

NCT06041698 2025-07-28

Two Implementation Strategies for the Collection of Electronic Patient-Reported Outcomes Among Patients With Multiple Myeloma

Thomas Jefferson University

Phase NA Completed
62 enrolled
Plasma cell

Multiple Myeloma

NCT03870633 2025-01-17

Assessment of Financial Difficulty in Participants with Chronic Lymphocytic Leukemia and Multiple Myeloma

Alliance for Clinical Trials in Oncology

Completed
521 enrolled
LymphoidOther hematologic neoplasmPlasma cell

Multiple Myeloma, Leukemia, Lymphocytic, Chronic, B-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡